Pharmacy

Roche ranked the most sustainable healthcare company in the DJSI

The FINANCIAL -- For the eleventh time, Roche has been recognised as the most sustainable company in the Pharmaceuticals index…

2 years ago

Gilead and Novo Nordisk announced new data from proof-of-concept trial in NASH

The FINANCIAL -- Gilead Sciences, Inc. and Novo Nordisk A/S announced results from a phase 2 proof-of-concept trial. The five-arm…

2 years ago

Metagenomi closes USD 65 million Series A financing led by Leaps by Bayer and Humboldt Fund

The FINANCIAL -- Metagenomi, a next generation gene editing company launched by UC Berkeley scientists in 2018, successfully completed a…

2 years ago

Pharmaceutical industries join to promise fair access to COVID-19 medicines and vaccines

The FINANCIAL -- On the occasion of the World Health Assembly, the world’s research-based and generic & biosimilar pharmaceutical industry bodies…

2 years ago

Bayer submits marketing authorization applications for finerenone in the U.S. and the EU

The FINANCIAL -- Bayer announced the submission of regulatory applications to the U.S. Food and Drug Administration (FDA) and the…

2 years ago

AstraZeneca’s Calquence approved in the EU for the treatment of most common type of leukaemia in adults

The FINANCIAL --  AstraZeneca’s Calquence (acalabrutinib), a next-generation selective Bruton’s tyrosine kinase (BTK) inhibitor, has been approved in the European Union…

2 years ago

FDA approved AstraZeneca’s Brilinta to reduce the risk of stroke

The FINANCIAL -- AstraZeneca’s Brilinta (ticagrelor) has been approved in the US to reduce the risk of stroke, a leading cause of disability…

2 years ago

Astellas announced that China NMPA approved XTANDI for the treatment of prostate cancer

The FINANCIAL -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") today announced that the China National…

2 years ago

Roche to present new data across 16 blood disorders at the ASH 2020 Annual Meeting

The FINANCIAL -- Roche  today announced that new data for its approved and investigational medicines will be presented at the…

2 years ago

EU approved AstraZeneca’s Forxiga for heart failure

The FINANCIAL -- AstraZeneca’s Forxiga (dapagliflozin) has been approved in the European Union (EU) for the treatment of symptomatic chronic heart failure…

2 years ago

Bayer reported sales decrease by 5.1%

The FINANCIAL -- Bayer reported third quarter financial results. Highlights Group sales decrease by 5.1 percent (Fx & portfolio adj.)…

2 years ago

EU Commission approved Roche’s Tecentriq in combination with Avastin for the treatment of people with liver cancer

The FINANCIAL -- Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the European Commission has approved Tecentriq® (atezolizumab) in…

2 years ago

AstraZeneca to sell commercial rights to Atacand in more than 70 countries to Cheplapharm

The FINANCIAL -- AstraZeneca has agreed to sell the commercial rights to Atacand (candesartan cilexetil) and Atacand Plus (a fixed-dose combination of candesartan cilexetil…

2 years ago

Novo Nordisk’s operating profit increased by 6% in Danish kroner and by 7% at constant exchange rates

The FINANCIAL - Novo Nordisk published financial report for the period 1 January 2020 to 30 September 2020 Sales increased…

2 years ago

Bayer launches first Global Creative Council

The FINANCIAL -- Bayer launches its first Global Creative Council. This global initiative brings together senior leaders from a variety…

2 years ago